The Global Implantable Cardiac Pacemaker Treatment market is expected to grow at at higher CAGR in the forecast period 2019-2026 owing to the increase in the elderly population, along with a sharp rise in the diabetic population globally

Hyderabad, June 19, 2019 -- The "Implantable Cardiac Pacemaker Treatment Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.

Atrial Fibrillation, the most common type of arrhythmia are estimated to be between 2.7 and 6.1 million which is projected to increase to 12.1 million by 2030 in the United States alone while globally the number is estimated to be 33 million which represents almost 0.5 % of the world’s population.

Request for free sample here : https://www.datamintelligence.com/research-report/implantable-cardiac-pacemaker-treatment-market

Implantable Cardiac Pacemaker Treatment Market Trends : Drivers and Restraints
⦁The Global implantable cardiac pacemakers market is driven by the increased prevalence of cardiovascular diseases worldwide, recent advances in technology and the increasing lifespan of individuals globally.
⦁As per the CDC, the number of patients suffering from Atrial Fibrillation, the most common type of arrhythmia are estimated to be between 2.7 and 6.1 million which is projected to increase to 12.1 million by 2030 in the United States alone while globally the number is estimated to be 33 million which represents almost 0.5 % of the world’s population. The rapid growth is attributed to the increase in the elderly population, along with a sharp rise in the diabetic population globally. Recent advances in technology such as the development of leadless pacemakers, CRT-P pacemakers and new pacemaker algorithms along with the increasing rate of diagnosis may lead to further adoption of pacemakers globally. Along with these factors, due to the increasing life expectancy of individuals, the number of pacemaker implants required over a lifetime could increase, leading to potentially higher sales.
⦁The global market for implantable cardiac pacemakers is being restrained by factors such as the high costs of surgery along with low reimbursement from insurance providers, increasing pacemaker battery life along with new product developments and market competition from implantable cardiac defibrillators.
⦁The market is also restrained by recent reports of malfunctions in CRT-Ps, leading to product recalls. Increasing pacemaker battery life and the new product developments such as the heart-powered pacemakers may lead to a decline in the number of pacemakers required by an individual over their lifetime, leading to lower product sales. The product itself faces rising competition from ICDs, S-ICD’s and CRT-Ds whose increasing adoption has led to a decline in the sales of implantable cardiac pacemakers.

Implantable Cardiac Pacemaker Treatment Market Segmentation:
The Global Implantable Cardiac Pacemaker Treatment market report segments the market by product type, by end-user, and by region.
⦁By Type
i.Single Chamber
ii.Dual Chamber
iii.Bi-ventricular acemakers
⦁By Application
i.Bradycardia
ii.Atrial fibrillation
iii.Sick sinus syndrome
iv.Long QT syndrome and heart block
v.Others
⦁By MRI compatibility
i.3-T Compatible
ii.1.5-T Compatible
iii.MRI incompatible pacemakers
⦁By End-Users
i.Hospitals
ii.Ambulatory surgical clinics
iii.Others

Key Points covered in the report

⦁Implantable Cardiac Pacemaker Treatment Market – Methodology and Scope
⦁Implantable Cardiac Pacemaker Treatment Market - Trends
⦁Implantable Cardiac Pacemaker Treatment Market – Industry Analysis
⦁Geographical Analysis
⦁Competitive Landscape
⦁Company Profiles

Implantable Cardiac Pacemaker Treatment Market Key Companies
Medtronic Plc, Boston Scientific, Abbot Laboratories, Shree Pacetronix Ltd, Vitatron Holding B.V, Medico S.p.A,, Biotronik Inc., MicroPort Scientific Corporation, Lepu Medical Technology Co. Ltd., Cardioelectronica.
DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research. Get more insights about the market here : https://www.datamintelligence.com/research-report/implantable-cardiac-pacemaker-treatment-market

About DataM Intelligence :
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historic data but also allows a highly justifiable forecast model.
DMI is currently strengthening its cross-industrial database for sectors including Chemicals, Materials, Agriculture, Healthcare Services, Animal Nutrition, Consumer Goods, Food & Beverages, Industrial Machinery and Automation among others.

1st floor, Phoenix Tech Tower, Plo no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence.

This release was published on openPR.